Mar 2021 $2 M No. 9 Under $2 million 7
mBio Diagnostics, Inc.: Raise no. 9, Mar 2021 × Investors in this round 7 investors had bought by the notice of Mar 22, 2021: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher Myatt · Executive Officer, Director Andrew Drenick · Director Judith O'Brien · Director Michael Chang · Director Robert Silverman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Christopher Myatt, CEO, by Tyler Hayden, Attorney-in-Fact. Source: SEC Form D, newest notice filed Mar 22, 2021. Read the notice at the SEC .
debt, options SEC Feb 2021 $10 M No. 8 $2 to $10 million 1
mBio Diagnostics, Inc.: Raise no. 8, Feb 2021 × Investors in this round 1 investor had bought by the notice of Feb 2, 2021: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher Myatt · Executive Officer, Director Andrew Drenick · Director Judith O'Brien · Director Michael Chang · Director Robert Silverman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Securities issued include a promissory note in the aggregate principal amount of $9,000,000 and a warrant to purchase $990,000 of the company's Series B Preferred Stock or next round of Preferred Stock.”Signed by Christopher Myatt, CEO, by Tyler Hayden, Attorney-in-Fact. Source: SEC Form D, newest notice filed Feb 2, 2021. Read the notice at the SEC .
debt, options SEC Jul 2020 $6 M No. 7 $2 to $10 million 16
mBio Diagnostics, Inc.: Raise no. 7, Jul 2020 × Investors in this round 16 investors had bought by the notice of Aug 3, 2020: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $11 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher Myatt · Executive Officer, Director Andrew Drenick · Director Judith O'Brien · Director Michael Chang · Director Robert Silverman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total amount sold includes the conversion of convertible promissory notes in the principal amount of $3,231,350.”Signed by Christopher J. Myatt, CEO, by Tyler Hayden, Attorney-in-Fact. Source: SEC Form D and 1 amendment, newest notice filed Aug 3, 2020. Read the notice at the SEC .
equity SEC Feb 2020 $2 M No. 6 Under $2 million 2
mBio Diagnostics, Inc.: Raise no. 6, Feb 2020 × Investors in this round 2 investors had bought by the notice of Mar 24, 2020: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Chris Myatt · Executive Officer, Director Andrew Drenick · Director Milton Chang · Director Robert Silverman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The total offering amount includes Convertible Promissory Notes in the aggregate principal amount of $2,000,000 and Warrants representing 20% of the principal amount of the Convertible Promissory Notes.”Signed by Christopher J. Myatt, CEO, by Tyler Hayden, Attorney-in-Fact. Source: SEC Form D and 1 amendment, newest notice filed Mar 24, 2020. Read the notice at the SEC .
debt, options SEC Aug 2018 $5 M No. 5 $2 to $10 million 10
mBio Diagnostics, Inc.: Raise no. 5, Aug 2018 × Investors in this round 10 investors had bought by the notice of Aug 22, 2018: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $6 M offered; $1 M still to sell
Smallest investment taken $25,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher J. Myatt · Executive Officer, Director · CEO Michael J. Lochhead · Executive Officer · Executive VP/CTO Milton J. Chang · Director Robert J. Silverman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes the conversion of $1,906,031.78 in convertible promissory notes.”Signed by Christopher J. Myatt, CEO, By Tyler Hayden, Attorney-In-Fact. Source: SEC Form D, newest notice filed Aug 22, 2018. Read the notice at the SEC .
equity SEC May 2018 $1 M No. 4 Under $2 million 1
mBio Diagnostics, Inc.: Raise no. 4, May 2018 × Investors in this round 1 investor had bought by the notice of May 21, 2018: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $2 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher J Myatt · Executive Officer, Director · CEO Michael J Lochhead · Executive Officer · Exec VP/CTO Sarah J Hatcher · Executive Officer · Corporate Secretary Milton J Chang · Director Robert J Silverman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The Company offered to purchase up to $1,500,000 Convertible Notes and Warrants representing 20% of the principal amount of the Convertible Notes.”Signed by Christopher J. Myatt, Ceo. Source: SEC Form D, newest notice filed May 21, 2018. Read the notice at the SEC .
debt, options SEC May 2015 $6 M No. 3 $2 to $10 million 14
mBio Diagnostics, Inc.: Raise no. 3, May 2015 × Investors in this round 14 investors had bought by the notice of May 21, 2015: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken $10,000
What was sold equity, securities to be acquired by exercising them, other: Series B Convertible Preferred Stock, warrants to purchase Series B Convertible Preferred Stock and the exercise thereof. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher Myatt · Executive Officer, Director · Chief Executive Officer and Director Michael Lochhead · Executive Officer · EVP/CTO Sarah Hatcher · Executive Officer · Corporate Secretary Milton Chang · Director · Director Robert Silverman · Director · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Christopher J. Myatt, Ceo. Source: SEC Form D, newest notice filed May 21, 2015. Read the notice at the SEC .
equity SEC Aug 2012 $4 M No. 2 $2 to $10 million 9
mBio Diagnostics, Inc.: Raise no. 2, Aug 2012 × Investors in this round 9 investors had bought by the notice of Sep 5, 2012: 8 accredited, 1 not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher Myatt · Executive Officer, Director Milton Chang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Christopher Myat, Ceo. Source: SEC Form D, newest notice filed Sep 5, 2012. Read the notice at the SEC .
equity SEC Dec 2010 $2 M No. 1 $2 to $10 million 19
mBio Diagnostics, Inc.: Raise no. 1, Dec 2010 × Investors in this round 19 investors had bought by the notice of Jan 5, 2011: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity, other: Series AA Preferred Stock, Warrants to purchase shares of Series AA Preferred Stock and the exercise thereof
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher J. Myatt · Executive Officer, Director Sarah C. Hatcher · Executive Officer Milton J. Chang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes conversion of indebtedness”Signed by Christopher J. Myatt, Chief executive officer. Source: SEC Form D, newest notice filed Jan 5, 2011. Read the notice at the SEC .
equity SEC